These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3886949)

  • 21. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
    Dhawan VK; Maier MK; Nayyar M; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(5):328-30. PubMed ID: 6092007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hospital and district differences in susceptibilities to antibiotics of main clinical isolates].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y; Suzuki A; Kudo H; Hayasaka N; Toyoshima S; Yamazaki Y
    Jpn J Antibiot; 1990 Feb; 43(2):362-73. PubMed ID: 2194057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.
    Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S
    Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
    Shah PM; Schirmer KP; Helm EB; Stille W
    Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory and clinical studies of flomoxef].
    Nozue N; Ueda Y; Haga T; Muraoka A; Ono Y; Nishiya H; Miyashita H
    Jpn J Antibiot; 1987 Oct; 40(10):1774-86. PubMed ID: 3327964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa].
    Kubo M; Kato Y; Inamori Y
    Jpn J Antibiot; 1985 Dec; 38(12):3487-96. PubMed ID: 3938819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Laboratory and clinical studies of cefmenoxime in the pediatric field].
    Sekiguchi T; Miyao M; Kokawa T; Uyama Y; Mizui M; Tanaka H
    Jpn J Antibiot; 1982 Nov; 35(11):2570-7. PubMed ID: 6302338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
    Igari J; Shimoji K; Uezu N; Nakasone I; Taira K; Kakazu R
    Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
    Gooch WM; Daly JA
    Antimicrob Agents Chemother; 1985 Aug; 28(2):343-6. PubMed ID: 3879661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
    Matsuoka A; Sumi K; Yoshimoto H; Takase M; Takashima S; Mimura K
    Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laboratory and clinical studies of cefmenoxime in pediatric infections].
    Miyachi Y; Nakashima T; Aso K; Nishikawa K; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1982 Oct; 35(10):2459-67. PubMed ID: 6306297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.